Literature DB >> 1776830

Involvement of p53 gene in the allelic deletion of chromosome 17p in human ovarian tumors.

S W Tsao1, C H Mok, K Oike, M Muto, H M Goodman, E E Sheets, R S Berkowitz, R C Knapp, C C Lau.   

Abstract

Previous reports have shown that one copy of the chromosome 17 was frequently lost in human ovarian cancers (1). The position of the allelic deletion has not been mapped and involvement of p53 gene has not been determined. In this study, we have shown that in human ovarian carcinoma, the commonest region of allelic loss in chromosome 17p is 17p 13.3 (65%) and 17p13.1 (63.7%; 6 out of 9 informative cases). Allelic loss was also observed at region 17p12 - 11.1 but at a lower frequency (38.6% to 37.5%). The pattern of allelic loss of p53 gene was consistent in both primary and secondary metastatic tumors of the same patient. No gross rearrangement of p53 was however observed at the remaining allele using Southern blot analysis. Allelic loss of p53 gene was closely associated with 17p 13.3, the terminal portion of chromosome 17p. The high frequency of allelic loss of p53 gene in ovarian carcinomas conformed with recent findings in cancers of colon, breast, lung and brain suggesting inactivation of p53 gene play a rate limiting step in pathogenesis of human malignancies.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1776830

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  8 in total

1.  Somatic mutations of the PPP2R1B candidate tumor suppressor gene at chromosome 11q23 are infrequent in ovarian carcinomas.

Authors:  R Wu; D C Connolly; X Ren; E R Fearon; K R Cho
Journal:  Neoplasia       Date:  1999-10       Impact factor: 5.715

2.  Multiplex PCR screening detects small p53 deletions and insertions in human ovarian cancer cell lines.

Authors:  I B Runnebaum; X W Tong; V Moebus; V Heilmann; D G Kieback; R Kreienberg
Journal:  Hum Genet       Date:  1994-06       Impact factor: 4.132

Review 3.  The genetic analysis of ovarian cancer.

Authors:  A N Shelling; I E Cooke; T S Ganesan
Journal:  Br J Cancer       Date:  1995-09       Impact factor: 7.640

4.  Allele loss from large regions of chromosome 17 is common only in certain histological subtypes of ovarian carcinomas.

Authors:  J Papp; B Csokay; P Bosze; Z Zalay; J Toth; B Ponder; E Olah
Journal:  Br J Cancer       Date:  1996-11       Impact factor: 7.640

5.  p53 mutation is associated with high S-phase fraction in primary fallopian tube adenocarcinoma.

Authors:  I B Runnebaum; T Köhler; E Stickeler; H R Kieback; R Kreienberg
Journal:  Br J Cancer       Date:  1996-10       Impact factor: 7.640

6.  Loss of heterozygosity and amplification on chromosome 11q in human ovarian cancer.

Authors:  W D Foulkes; I G Campbell; G W Stamp; J Trowsdale
Journal:  Br J Cancer       Date:  1993-02       Impact factor: 7.640

7.  Frequent loss of heterozygosity on chromosome 17 at 17q11.2-q12 in Barrett's adenocarcinoma.

Authors:  A Swift; J M Risk; A N Kingsnorth; T A Wright; M Myskow; J K Field
Journal:  Br J Cancer       Date:  1995-05       Impact factor: 7.640

8.  Alteration of the p53 tumor suppressor gene occurs independently of K-ras activation and more frequently in serous adenocarcinomas than in other common epithelial tumors of the human ovary.

Authors:  M Fujita; T Enomoto; M Inoue; O Tanizawa; M Ozaki; J M Rice; T Nomura
Journal:  Jpn J Cancer Res       Date:  1994-12
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.